Palvella Therapeutics (PVLA) EBT Margin (2014 - 2024)
Palvella Therapeutics' (PVLA) quarterly EBT Margin came in at 4784.91% in Q1 2024, down 398834.0% year-on-year from N/an in Q2 2023, and down 794.02% on a QoQ basis from 535.21% in Q4 2023.
Palvella Therapeutics (PVLA) EBT Margin (2014 - 2024) Analysis & Trends
Palvella Therapeutics (PVLA) has 11 years of EBT Margin data on file, last reported at 4784.91% in Q1 2024.
- On a quarterly basis, EBT Margin fell 398834.0% year-over-year to 4784.91% in Q1 2024; TTM through Sep 2024 was 54.71%, a 3894.0% increase from a year earlier, with the FY2023 full-year figure at 48.28%, up 2407276.0% from the prior year.
- EBT Margin for Q1 2024 stood at 4784.91%, down from 535.21% in the prior quarter.
- Over the last five years, EBT Margin for PVLA reached as high as 370.89% in Q4 2020 and fell as low as 8991.97% in Q4 2022.
- Historically, EBT Margin has averaged 1705.98% across 5 years, with a median of 483.41% in 2021.
- Across the five-year window, EBT Margin sank 885341 bps in 2022 and surged 845676 bps in 2023, its largest moves.
- Year by year, EBT Margin stood at 370.89% in 2020, then tumbled by 137 bps to 138.56% in 2021, then slumped by 6389 bps to 8991.97% in 2022, then soared by 94 bps to 535.21% in 2023, then plunged by 794 bps to 4784.91% in 2024.
- Per Business Quant data, the three most recent EBT Margin figures were 4784.91% in Q1 2024, 535.21% in Q4 2023, and 63.05% in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Palvella Therapeutics | 318.78 Mn | 56.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -4,784.91% |
| Dec 31, 2023 | -535.21% |
| Sep 30, 2023 | -63.05% |
| Jun 30, 2023 | 7.79% |
| Mar 31, 2023 | -796.57% |
| Dec 31, 2022 | -8,991.97% |
| Sep 30, 2022 | -4,910.08% |
| Jun 30, 2022 | -5,621.74% |
| Mar 31, 2022 | -73.33% |
| Dec 31, 2021 | -138.56% |
| Sep 30, 2021 | -483.41% |
| Jun 30, 2021 | -2,330.34% |
| Mar 31, 2021 | -44.30% |
| Dec 31, 2020 | 370.89% |
| Sep 30, 2020 | -527.50% |
| Jun 30, 2020 | -48.08% |
| Mar 31, 2020 | -31.34% |
| Dec 31, 2019 | -4.46% |
| Sep 30, 2019 | -17.13% |
| Jun 30, 2019 | -220.52% |